Investigation launched into TG Therapeutics' officers for possible self-dealing harming shareholders.

Kuehn Law, PLLC is investigating whether certain officers and directors of TG Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. This legal probe could lead to damages for shareholders and reforms in corporate governance. Long-term shareholders are encouraged to contact the law firm to protect their rights, as there may be limited time to act. The investigation highlights concerns about management integrity affecting shareholder value.

As of Sep 28, 2026 20:21 WIB, TG Therapeutics Inc (TGTX) is trading at USD 57.30 on Pluang, showing a slight 1-day decline of 0.23%. The company holds a market capitalization of $8.79 billion and an enterprise value of $8.99 billion. This legal investigation may influence shareholder sentiment, but TGTX remains actively traded with a volume of 1,309,402 shares. The typical hold time for TGTX on Pluang is 15 days, indicating moderate investor engagement.